---
title: "Nicotinamide (NAA) (aka Niacinamide) Market, Global Outlook and Forecast 2025-2032"
datePublished: Sun Oct 12 2025 08:56:29 GMT+0000 (Coordinated Universal Time)
cuid: cmgngzpk6000202lb87zahrtb
slug: nicotinamide-naa-aka-niacinamide-market-global-outlook-and-forecast-2025-2032-1

---

# Nicotinamide (NAA) (aka Niacinamide) Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global Nicotinamide (NAA) (aka Niacinamide) market size was valued at USD 848 million in 2024. The market is projected to grow from USD 868 million in 2025 to USD 982 million by 2032, exhibiting a CAGR of 2.2% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/298423/global-nicotinamide-forecast-market-2025-2032-761">
            https://www.24chemicalresearch.com/download-sample/298423/global-nicotinamide-forecast-market-2025-2032-761</a></b></div><br><p>
</p><p>Nicotinamide, also known as niacinamide, is an essential vitamin B3 compound that plays a crucial role in cellular metabolism and energy production. With the chemical formula C6H6N2O, it functions as a precursor to coenzymes NAD+ and NADP+, which are vital for redox reactions in biological systems. The compound finds extensive applications across pharmaceutical formulations, nutritional supplements, and cosmetic products due to its anti-inflammatory and skin-protective properties.</p><p>
</p><p>The market growth is primarily driven by increasing demand from the animal feed sector, where nicotinamide accounts for over 60% of total consumption as a key nutritional additive. Furthermore, rising health consciousness among consumers and growing applications in dermatological treatments are contributing to market expansion. Asia Pacific dominates the global landscape with more than 35% market share, attributed to robust production capacities in China and India. Leading manufacturers like Lonza and Jubilant Life Sciences continue to invest in production scale-ups to meet the growing global demand across various industries.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand in Nutraceuticals and Cosmeceuticals to Fuel Market Expansion</strong></p><p>
</p><p>The global nicotinamide market is experiencing significant growth, primarily driven by its expanding applications in nutraceuticals and cosmeceuticals. As a key form of vitamin B3, nicotinamide plays a crucial role in cellular energy production and DNA repair, making it highly sought-after in dietary supplements. The nutraceutical sector currently accounts for over 25% of global nicotinamide consumption, with this share projected to increase as consumer awareness about preventive healthcare grows. Recent clinical studies have validated nicotinamide's benefits in managing cholesterol levels and reducing skin cancer risks, further accelerating adoption.</p><p>
</p><p>In the cosmetics industry, niacinamide has emerged as one of the most clinically proven anti-aging ingredients. Over 35% of new skincare product launches in 2023 featured nicotinamide as a key active ingredient. Its ability to improve skin barrier function and reduce hyperpigmentation has made it particularly valuable in the rapidly growing beauty and personal care segment, which is expected to drive steady demand through 2032.</p><p>
</p><p style="text-align:center"><strong>Expanding Animal Feed Sector to Drive Volume Growth</strong></p><p>
</p><p>Feed grade nicotinamide represents the largest product segment, accounting for more than 60% of the global market volume. This dominance stems from its essential role as a vitamin supplement in livestock and poultry nutrition. With global meat production projected to grow by 14% through 2030 to meet rising protein demand, feed additives like nicotinamide are becoming increasingly critical for optimal animal health and growth performance.</p><p>
</p><p>The Asia Pacific region, where feed production has grown at a compound annual rate of 5.2% over the past five years, continues to drive substantial demand. Government regulations mandating nutritional fortification of animal feed in emerging economies are creating a stable, long-term growth foundation for nicotinamide suppliers.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Price Volatility of Raw Materials to Impact Profit Margins</strong></p><p>
</p><p>The nicotinamide manufacturing process relies heavily on key chemical precursors including 3-cyanopyridine and ammonia, whose prices have shown significant volatility in recent years. Global supply chain disruptions and fluctuating energy costs have created pricing uncertainty, with raw material costs accounting for 60-70% of total production expenses. Many manufacturers operate on thin gross margins of 15-20%, leaving limited room to absorb these input cost increases.</p><p>
</p><p>Additionally, the capital-intensive nature of production facilities requires substantial upfront investment. Establishing a new nicotinamide production line with 10,000 MT annual capacity typically requires capital expenditure exceeding $50 million, creating high barriers to entry and limiting supply-side flexibility during demand surges.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Strict Regulatory Frameworks to Slow Product Approvals</strong></p><p>
</p><p>While nicotinamide enjoys generally recognized as safe (GRAS) status in most markets, increasing regulatory scrutiny presents challenges for product innovation. The European Food Safety Authority recently implemented more stringent documentation requirements for novel nutraceutical applications, extending approval timelines by 6-12 months. In pharmaceutical applications, purity requirements have tightened, with current good manufacturing practice (cGMP) standards now requiring impurity levels below 0.1% for oral dosage forms.</p><p>
</p><p>Emerging markets present additional challenges as regulatory systems mature. Countries like India and Brazil are implementing more comprehensive registration processes, requiring local clinical data for certain nicotinamide formulations. These evolving requirements create compliance costs that can reach $500,000 per product registration in some jurisdictions.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Therapeutic Applications to Create New Growth Avenues</strong></p><p>
</p><p>Recent research breakthroughs are opening significant opportunities in pharmaceutical applications. Phase III clinical trials have demonstrated nicotinamide's potential in treating autoimmune disorders and neurodegenerative conditions, with the neurological therapeutic segment projected to grow at 8.3% CAGR through 2030. The compound's role in NAD+ metabolism makes it particularly promising for age-related diseases, a market expected to exceed $30 billion globally by 2027.</p><p>
</p><p>The development of novel drug delivery systems, including sustained-release formulations and topical gels, is further expanding addressable markets. Pharmaceutical companies are increasingly seeking strategic partnerships with established nicotinamide manufacturers to secure high-purity supply for clinical development programs.</p><p>
</p><p style="text-align:center"><strong>Sustainable Production Methods to Differentiate Market Leaders</strong></p><p>
</p><p>Environmental considerations are driving innovation in production processes, with leading manufacturers investing in green chemistry approaches. New catalytic conversion methods have demonstrated 30-40% reductions in energy consumption while minimizing hazardous byproducts. These sustainable production technologies not only reduce operational costs but also align with the growing demand from brand owners for responsibly sourced ingredients.</p><p>
</p><p>Carbon footprint reduction has become a key competitive differentiator, with major consumer health companies now requiring detailed environmental impact data from their nicotinamide suppliers. Producers implementing renewable energy solutions and water recycling systems are better positioned to secure long-term contracts with multinational customers.</p><p>
</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Feed Grade Segment Dominates Due to Wide Application in Animal Nutrition</strong></p><p>
</p><p>The Nicotinamide (NAA) market is segmented based on type into:</p><p>
</p><p>Pharmaceutical Grade</p><p>Feed Grade</p><p>Food Grade</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Feed Additives Lead the Market Owing to Increased Demand in Livestock Production</strong></p><p>
</p><p>The market is segmented by application into:</p><p>
</p><p>Feed Additives</p><p>Food and Drinks Industry</p><p>Pharmaceutical Industry</p><p>Daily Chemicals</p><p>Others</p><p>
<strong>By End-User</strong></p><p>
</p><p><strong>Animal Nutrition Sector Accounts for Significant Market Share</strong></p><p>
</p><p>The market is segmented by end-user into:</p><p>
</p><p>Animal Feed Manufacturers</p><p>Food Processing Companies</p><p>Pharmaceutical Companies</p><p>Cosmetic and Personal Care Manufacturers</p><p>
<strong>By Function</strong></p><p>
</p><p><strong>Nutritional Supplementation Function Gains Prominence in Multiple Industries</strong></p><p>
</p><p>The market is segmented by function into:</p><p>
</p><p>Nutritional Supplementation</p><p>Vitamin B3 Source</p><p>Skin Health Applications</p><p>Metabolic Function Support</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Leading Manufacturers Focus on Capacity Expansion to Meet Rising Demand</strong></p><p>
</p><p>The global nicotinamide (NAA) market exhibits a moderately consolidated structure, dominated by established chemical and pharmaceutical manufacturers while accommodating smaller regional producers. <strong>Lonza</strong> emerges as the clear market leader, commanding approximately <strong>50%</strong> of global production capacity according to recent industry analysis. Their dominance stems from vertically integrated manufacturing facilities, stringent quality control systems, and long-term contracts with multinational pharmaceutical companies.</p><p>
</p><p><strong>Jubilant Life Sciences</strong> and <strong>Vertellus</strong> collectively account for nearly <strong>25%</strong> of global output, benefiting from cost-efficient production bases in Asia and diversified product offerings. Both companies have recently announced capacity expansion projects to capitalize on growing demand from the animal nutrition sector, which consumes over <strong>60%</strong> of global NAA production.</p><p>
</p><p>The competitive intensity continues to rise as mid-sized players adopt strategic differentiation approaches. <strong>Brother Enterprises</strong> has carved a niche in high-purity pharmaceutical-grade NAA through specialized crystallization technologies, while <strong>DSM</strong> leverages its strong foothold in the European food fortification market with tailored vitamin B3 formulations.</p><p>
</p><p>Recent market shifts show Chinese manufacturers like <strong>Zhejiang Lanbo Biotechnology</strong> rapidly gaining share through competitive pricing and improved product quality, though export restrictions on key raw materials remain a challenge. The industry anticipates further consolidation as larger players seek to acquire regional manufacturers for geographic diversification.</p><p>
<strong>List of Key Nicotinamide (NAA) Manufacturers</strong></p><p>
</p><p>Lonza Group AG (Switzerland)</p><p>Jubilant Life Sciences Ltd. (India)</p><p>Vertellus Holdings LLC (U.S.)</p><p>Brother Enterprises Holding Co., Ltd. (China)</p><p>Zhejiang Lanbo Biotechnology Co., Ltd. (China)</p><p>Lasons India Pvt. Ltd. (India)</p><p>Vanetta (China)</p><p>DSM Nutritional Products (Netherlands)</p><p>Tianjin Zhongrui Pharmaceutical Co., Ltd. (China)</p><p>
</p><p>
<strong>NICOTINAMIDE (NAA) (AKA NIACINAMIDE) MARKET TRENDS</strong></p><p>
<strong>Growing Demand in Pharmaceutical and Nutraceutical Industries Drives Market Expansion</strong></p><p>
</p><p>The global nicotinamide market is experiencing steady growth, projected to reach $982 million by 2032, driven by increasing applications in pharmaceuticals and nutraceuticals. As a key component of vitamin B3, niacinamide plays a crucial role in cellular metabolism and is widely used in treatments for pellagra and hyperlipidemia. The pharmaceutical sector accounts for approximately 25% of total demand, with rising adoption in dermatological treatments due to its anti-inflammatory properties. Furthermore, its incorporation into nutraceuticals for skin health and energy metabolism supplements has seen a compound annual growth rate of 4.1% between 2020-2024.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Feed Grade Segment Dominates Industrial Applications</strong></p><p>
</p><p>With over 60% market share, the feed grade segment leads commercialization due to widespread use in animal nutrition. Livestock producers increasingly recognize niacinamide's role in improving feed conversion efficiency and preventing deficiency-related disorders. Asia-Pacific, representing 35% of global consumption, demonstrates particularly strong growth in this segment because of expanding meat production capacities in China and India. Regulatory approvals for higher supplementation levels in poultry and swine feed have further accelerated adoption rates in the region.</p><p>
<strong>Technological Advancements in Production Processes</strong></p><p>
</p><p>Manufacturers are investing heavily in enzymatic synthesis methods to improve yield efficiency and sustainability. Recent process optimizations have reduced energy consumption by 18-22% compared to traditional chemical synthesis routes. Market leader Lonza has pioneered continuous flow production systems that increase output capacity while maintaining 99.5% purity standards. These innovations are critical as environmental regulations become stricter, particularly in European and North American markets where green chemistry initiatives influence purchasing decisions.</p><p>
</p><p>
<strong>Regional Analysis: Nicotinamide (NAA) (aka Niacinamide) Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American Nicotinamide market is characterized by strong demand from pharmaceutical and nutraceutical sectors, driven by increasing consumer awareness regarding vitamin B3 benefits. The U.S. holds the dominant share, with feed additives accounting for over 40% of regional consumption due to a well-established livestock industry. Regulatory approvals from the FDA for nicotinamide usage in dietary supplements have further boosted market growth. However, pricing pressures from cheaper Asian imports present challenges for domestic manufacturers. The region is witnessing rising demand for pharmaceutical-grade nicotinamide, particularly for dermatological applications in skincare products.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe maintains stringent quality standards for nicotinamide production, particularly for pharmaceutical and food-grade applications. Germany and France lead in consumption, with the cosmetic industry driving significant demand for high-purity niacinamide in anti-aging formulations. The EU's REACH regulations ensure product safety but add compliance costs for manufacturers. Feed-grade nicotinamide dominates the market volume, though growth is slowing due to shifting livestock regulations. Recent investments in sustainable production methods by key players like Lonza are reshaping the competitive landscape, with an emphasis on eco-friendly manufacturing processes.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
As the largest global market with over 35% share, Asia-Pacific's growth is propelled by China's massive feed additive industry and India's expanding pharmaceutical sector. China leads production and consumption, hosting several major manufacturers. The region shows increasing demand for food-grade nicotinamide in functional foods and beverages. While price sensitivity remains a key market characteristic, premium applications in cosmetics and pharmaceuticals are gaining traction in developed Asian markets like Japan and South Korea. Infrastructure developments and rising disposable incomes are driving diversified demand across the region.</p><p>
</p><p><strong>South America</strong></p><p>
The South American market shows moderate growth, with Brazil as the primary consumer of feed-grade nicotinamide for its poultry and swine industries. Pharmaceutical applications are emerging but remain limited by regulatory hurdles and economic instability. Local production capacity is constrained, leading to reliance on imports from China and India. Recent economic challenges have slowed market expansion, though long-term potential exists in the nutraceutical segment as health awareness grows among middle-class populations in urban centers.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This region represents an emerging market with growth centered in GCC countries and South Africa. Pharmaceutical applications show promise due to increasing healthcare expenditure, while feed additives dominate current consumption patterns. Limited local manufacturing capabilities result in high import dependency. Market development faces challenges from price volatility and fragmented distribution networks, though urbanization and rising health consciousness are creating new opportunities in consumer health products. The cosmetics industry is beginning to adopt niacinamide in premium skincare lines, particularly in affluent Middle Eastern markets.</p><p>

<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Nicotinamide (NAA) (aka Niacinamide), covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Nicotinamide (NAA) (aka Niacinamide) companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Nicotinamide (NAA) Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global Nicotinamide (NAA) market was valued at <strong>USD 848 million in 2024</strong> and is projected to reach <strong>USD 982 million by 2032</strong>, growing at a CAGR of <strong>2.2%</strong> during the forecast period.</p><p>
<strong>Which key companies operate in Global Nicotinamide (NAA) Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology, Lasons India, Vanetta, DSM, and Tianjin Zhongrui Pharmaceutical</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for dietary supplements, increasing applications in animal feed, and growing awareness about skincare benefits</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the largest market, holding <strong>over 35% share</strong>, while <strong>North America and Europe</strong> follow as significant markets.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>expansion of pharmaceutical applications, rising demand for high-purity niacinamide in cosmetics, and increasing use in functional foods</strong>.</p><p>
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/298423/global-nicotinamide-forecast-market-2025-2032-761">
            https://www.24chemicalresearch.com/reports/298423/global-nicotinamide-forecast-market-2025-2032-761</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 Nicotinamide (NAA) (aka Niacinamide) Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global Nicotinamide (NAA) (aka Niacinamide) Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global Nicotinamide (NAA) (aka Niacinamide) Overall Market Size<br />
 2.1 Global Nicotinamide (NAA) (aka Niacinamide) Market Size: 2024 VS 2032<br />
 2.2 Global Nicotinamide (NAA) (aka Niacinamide) Market Size, Prospects & Forecasts: 2020-2032<br />
 2.3 Global Nicotinamide (NAA) (aka Niacinamide) Sales: 2020-2032<br />
3 Company Landscape<br />
 3.1 Top Nicotinamide (NAA) (aka Niacinamide) Players in Global Market<br />
 3.2 Top Global Nicotinamide (NAA) (aka Niacinamide) Companies Ranked by Revenue<br />
 3.3 Global Nicotinamide (NAA) (aka Niacinamide) Revenue by Companies<br />
 3.4 Global Nicotinamide (NAA) (aka Niacinamide) Sales by Companies<br />
 3.5 Global Nicotinamide (NAA) (aka Niacinamide) Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 Nicotinamide (NAA) (aka Niacinamide) Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers Nicotinamide (NAA) (aka Niacinamide) Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 Nicotinamide (NAA) (aka Niacinamide) Players in Global Market<br />
 3.8.1 List of Global Tier 1 Nicotinamide (NAA) (aka Niacinamide) Companies<br />
 3.8.2 List of Global </p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/298423/global-nicotinamide-forecast-market-2025-2032-761">
            https://www.24chemicalresearch.com/reports/298423/global-nicotinamide-forecast-market-2025-2032-761</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>